Ben Huffman

Pfizer (United States)

Papers

1

Total Citations

4

H-Index

1

About

Ben Huffman is a bioprocess engineer whose work focuses on accelerating the development and understanding of biopharmaceutical manufacturing. His primary research areas include high throughput process development (HTPD), particle conditioning operations, and the integration of automation and analytics to streamline biologics production. Huffman’s major contribution lies in pioneering scalable, miniaturized systems that enable rapid screening of critical unit operations, particularly in particle conditioning—a key step in drug substance purification. His most cited work, “High throughput screening of particle conditioning operations: I. System design and method development” (2015, 4 citations), establishes a foundational framework for using small-volume, parallel processing to assess process parameters with high efficiency. This approach directly addresses industry pressures to reduce time-to-market and development costs while satisfying regulatory demands for deeper process understanding. By demonstrating that HTPD can deliver robust, predictive data for particle conditioning, Huffman has helped bridge the gap between early-stage development and commercial manufacturing. His contributions are particularly valuable for researchers and engineers seeking to implement quality-by-design principles in biotech, offering a practical pathway to faster, more informed process characterization.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
High throughput screening of particle conditioning operations: I. System design and method development
4 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Pfizer (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago